Re-thinking of T-tube use in whole liver transplantation: an analysis on the risk of delayed graft function.

Bile acids Early allograft dysfunction External biliary drainage Liver transplantation T-tube

Journal

Updates in surgery
ISSN: 2038-3312
Titre abrégé: Updates Surg
Pays: Italy
ID NLM: 101539818

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 25 11 2021
accepted: 28 02 2022
pubmed: 25 3 2022
medline: 13 4 2022
entrez: 24 3 2022
Statut: ppublish

Résumé

The liver-gut axis has been identified as crucial mediator of liver regeneration. Thus, the use of a T-tube in liver transplantation (LT), which interrupts the enterohepatic bile circulation, may potentially have a detrimental effect on the early allograft functional recovery. We retrospectively analyzed a cohort of 261 patients transplanted with a whole liver graft, with a duct-to-duct biliary anastomosis, who did not develop any surgical complication within postoperative day 14. Early allograft dysfunction (EAD) was defined according to the criteria of Olthoff et al. (EAD-O), and graded according to the Model for Early Allograft Function (MEAF) score. EAD-O developed in 24.7% of recipients and the median MEAF score was 4.0 [interquartile range 2.9-5.5]. Both MEAF and EAD predicted 90-day post-LT mortality. A T-tube was used in 49.4% of cases (n = 129). After a propensity score matching for donor age, cold and warm ischemia time, donor risk index, balance of risk score, Child-Pugh class C, and MELD score, the T-tube group showed a significantly higher prevalence of EAD-O and value of MEAF than the no-T-tube group (EAD-O: 29 [34.1%] vs 16 [19.0%], p = 0.027; MEAF 4.5 [3.5-5.7] vs 3.7 [2.9-5.0], p = 0.014). In conclusion, T-tube use in LT may be a risk factor for EAD and higher MEAF, irrespective of graft quality and severity of pre-LT liver disease.

Identifiants

pubmed: 35325442
doi: 10.1007/s13304-022-01267-9
pii: 10.1007/s13304-022-01267-9
pmc: PMC8995289
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

571-577

Informations de copyright

© 2022. The Author(s).

Références

Jochmans I, Fieuws S, Monbaliu D, Pirenne J (2017) “Model for Early Allograft Function” Outperforms “Early Allograft Dysfunction” as a predictor of transplant survival. Transplantation 101(8):e258–e264
doi: 10.1097/TP.0000000000001833
Olthoff KM, Kulik L (2010) Samstein B Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl 16(8):943–949
doi: 10.1002/lt.22091
Hoyer DP, Paul A, Gallinat A et al (2015) Donor information based prediction of early allograft dysfunction and outcome in liver transplantation. Liver Int 35(1):156–163
doi: 10.1111/liv.12443
Pareja E, Cortes M, Hervás D et al (2015) A score model for the continuous grading of early allograft dysfunction severity. Liver Transpl 21:38–46
doi: 10.1002/lt.23990
Dong X, Zhao H, Ma X, Wang S (2010) Reduction in bile acid pool causes delayed liver regeneration accompanied by down-regulated expression of FXR and c-Jun mRNA in rats. J Huazhong Univ Sci Technol Med Sci 30(1):55–60
doi: 10.1007/s11596-010-0110-8
Naugler WE (2014) Bile acid flux is necessary for normal liver regeneration. PLoS ONE 9(5):e97426
doi: 10.1371/journal.pone.0097426
van de Laarschot LF, Jansen PL, Schaap FG, Olde Damink SW (2016) The role of bile salts in liver regeneration. Hepatol Int 10(5):733–740
doi: 10.1007/s12072-016-9723-8
Bednarsch J, Blüthner E, Malinowski M, Seehofer D, Pratschke J, Stockmann M (2016) Regeneration of liver function capacity after partial liver resection is impaired in case of postoperative bile leakage. World J Surg 40(9):2221–2228
doi: 10.1007/s00268-016-3524-z
Watanabe K, Yokoyama Y, Kokuryo T et al (2010) Segmental cholangitis impairs hepatic regeneration capacity after partial hepatectomy in rats. HPB (Oxford) 12(10):664–673
doi: 10.1111/j.1477-2574.2010.00229.x
Takagi T, Yokoyama Y, Kokuryo T, Yamaguchi J, Nagino M (2015) Liver regeneration following experimental major hepatectomy with choledochojejunostomy. Br J Surg 102(11):1410–1417
doi: 10.1002/bjs.9908
Otao R, Beppu T, Isiko T et al (2012) External biliary drainage and liver regeneration after major hepatectomy. Br J Surg 99(11):1569–1574
doi: 10.1002/bjs.8906
Flores A, Asrani SK (2017) The donor risk index: a decade of experience. Liver Transpl 23(9):1216–1225
doi: 10.1002/lt.24799
Dutkowski P, Oberkofler CE, Slankamenac K et al (2011) Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. Ann Surg 254(5):745–753
doi: 10.1097/SLA.0b013e3182365081
Fukazawa K, Nishida S, Pretto EA Jr, Vater Y, Reyes JD (2016) Detrimental graft survival of size-mismatched graft for high model for end-stage liver disease recipients in liver transplantation. J Hepatobiliary Pancreat Sci 23(7):406–413
doi: 10.1002/jhbp.355
Austin PC (2011) Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 10:150–161
doi: 10.1002/pst.433
Riediger C, Müller MW, Michalski CW et al (2010) T-Tube or no T-tube in the reconstruction of the biliary tract during orthotopic liver transplantation: systematic review and meta-analysis. Liver Transpl 16:705
pubmed: 20517904
Song S, Lu T, Yang W et al (2021) T-tube or no T-tube for biliary tract reconstruction in orthotopic liver transplantation: an updated systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol 15(10):1201–1213
doi: 10.1080/17474124.2021.1903874
Zhao JZ, Qiao LL, Du ZQ et al (2021) T-tube vs no T-tube for biliary tract reconstruction in adult orthotopic liver transplantation: an updated systematic review and meta-analysis. World J Gastroenterol 27(14):1507–1523
doi: 10.3748/wjg.v27.i14.1507
Pravisani R, De Simone P, Patrono D et al (2021) An Italian survey on the use of T-tube in liver transplantation: old habits die hard! Updates Surg 73(4):1381–1389
doi: 10.1007/s13304-021-01019-1
Czigany Z, Scherer MN, Pratschke J et al (2019) Technical aspects of orthotopic liver transplantation-a survey-based study within the eurotransplant, swisstransplant, scandiatransplant, and British transplantation society networks. J Gastrointest Surg 23(3):529–537
doi: 10.1007/s11605-018-3915-6
Sun N, Zhang J, Li X, Zhang C, Zhou X, Zhang C (2015) Biliary tract reconstruction with or without T-tube in orthotopic liver transplantation: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol 9(4):529–538
doi: 10.1586/17474124.2015.1002084
Akamatsu N, Sugawara Y, Hashimoto D (2011) Biliary reconstruction, its complications and management of biliary complications after adult liver transplantation: a systematic review of the incidence, risk factors and outcome. Transpl Int 24(4):379–392
doi: 10.1111/j.1432-2277.2010.01202.x
Maeda T, Yokoyama Y, Ebata T et al (2019) Discrepancy between volume and functional recovery in early phase liver regeneration following extended hepatectomy with extrahepatic bile duct resection. Hepatol Res 49(10):1227–1235
doi: 10.1111/hepr.13378
Pravisani R, Baccarani U, Eguchi S (2019) In search of a pathogenesis for impaired liver regeneration after major hepatectomy with extrahepatic bile duct resection: the plot thickens! Hepatol Res 49(10):1091–1093
doi: 10.1111/hepr.13414
Lenzen R, Bähr A, Eichstädt H et al (1999) In liver transplantation, T tube bile represents total bile flow: physiological and scintigraphic studies on biliary secretion of organic anions. Liver Transpl Surg 5(1):8–15
doi: 10.1002/lt.500050112
Liu HX, Keane R, Sheng L, Wan YJ (2015) Implications of microbiota and bile acid in liver injury and regeneration. J Hepatol 63(6):1502–1510
doi: 10.1016/j.jhep.2015.08.001
Jin LH, Fang ZP, Fan MJ, Huang WD (2019) Bile-ology: from bench to bedside. J Zhejiang Univ Sci B 20(5):414–427
doi: 10.1631/jzus.B1900158
Cornide-Petronio ME, Álvarez-Mercado AI, Jiménez-Castro MB, Peralta C (2020) Current knowledge about the effect of nutritional status, supplemented nutrition diet, and gut microbiota on hepatic ischemia-reperfusion and regeneration in liver surgery. Nutrients 12(2):284
doi: 10.3390/nu12020284
Said A, Safdar N, Lucey MR et al (2004) Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention. Am J Transplant 4(4):574–582
doi: 10.1111/j.1600-6143.2004.00374.x
Sotiropoulos GC, Sgourakis G, Radtke A et al (2009) Orthotopic liver transplantation: T-tube or not T-tube? Systematic review and meta-analysis of results. Transplantation 87(11):1672–1680
doi: 10.1097/TP.0b013e3181a5cf3f
López-Andújar R, Maupoey J, Escrig J et al (2019) Selective Indication of T-Tube in Liver transplantation: prospective validation of the results of a randomized controlled trial. Transplant Proc 51(1):44–49
doi: 10.1016/j.transproceed.2018.03.133

Auteurs

Riccardo Pravisani (R)

Liver-Kidney Transplantation Unit, Department of Medicine, University of Udine, Udine, Italy. riccardo.pravisani@gmail.com.

Miriam Isola (M)

Division of Medical Statistic, Department of Medicine, University of Udine, Udine, Italy.

Dario Lorenzin (D)

Liver-Kidney Transplantation Unit, Department of Medicine, University of Udine, Udine, Italy.

Vittorio Cherchi (V)

Liver-Kidney Transplantation Unit, Department of Medicine, University of Udine, Udine, Italy.

Erica Boscolo (E)

Liver-Kidney Transplantation Unit, Department of Medicine, University of Udine, Udine, Italy.

Federico Mocchegiani (F)

HPB Surgery and Transplantation Unit, Department of Clinical and Experimental Medicine, Polytechnic University of Marche, Ancona, Italy.

Giovanni Terrosu (G)

Liver-Kidney Transplantation Unit, Department of Medicine, University of Udine, Udine, Italy.

Umberto Baccarani (U)

Liver-Kidney Transplantation Unit, Department of Medicine, University of Udine, Udine, Italy.
Dipartimento Di Area Medica, University of Udine, P.Le Kolbe, Via Colugna 50, 33100, Udine, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH